Home | | Pharmaceutical Biotechnology: Fundamentals and Applications | Monoclonal Antibodies Administered Following Transplant

Chapter: Pharmaceutical Biotechnology: Fundamentals and Applications - Monoclonal Antibodies in Solid Organ Transplantation

| Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail |

Monoclonal Antibodies Administered Following Transplant

Monoclonal antibodies given following transplanta-t ion are u sed to t re at allograft rejection.

Monoclonal Antibodies Administered Following Transplant

 

Monoclonal antibodies given following transplanta-t ion are u sed to t re at allograft rejection. Administration of these agents is mainly reserved for severe allograft rejection in which the immunolo-gic insult must be controlled quickly. Under normal homeostatic conditions the humoral immune system provides immediate control of infectious pathogens through secretion of antibodies. Cell mediated im-munity, in addition to fighting infections, provides surveillance against the production of mutant cells capable of oncogenesis. Interruption of either of these immune systems through the use of monoclonal antibodies places these patients at significant risk for infection and malignancy. Careful post administration assessment of infection and post-transplant malig-nancy is commonplace.

 

 

Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail


Copyright © 2018-2020 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.